| 000 | 01892 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516032247.0 | ||
| 264 | 0 | _c20111007 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1432-2277 | ||
| 024 | 7 |
_a10.1111/j.1432-2277.2011.01253.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuadalix, Sonsoles | |
| 245 | 0 | 0 |
_aEffect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _cJul 2011 |
||
| 300 |
_a657-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xtherapeutic use |
| 650 | 0 | 4 |
_aCholecalciferol _xtherapeutic use |
| 650 | 0 | 4 |
_aEtidronic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisedronic Acid |
| 650 | 0 | 4 |
_aSpinal Fractures _xprevention & control |
| 700 | 1 | _aMartínez-Díaz-Guerra, Guillermo | |
| 700 | 1 | _aLora, David | |
| 700 | 1 | _aVargas, Carmela | |
| 700 | 1 | _aGómez-Juaristi, Miren | |
| 700 | 1 | _aCobaleda, Belén | |
| 700 | 1 | _aGonzález, Enrique Moreno | |
| 700 | 1 | _aHawkins, Federico | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 24 _gno. 7 _gp. 657-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1432-2277.2011.01253.x _zAvailable from publisher's website |
| 999 |
_c20734438 _d20734438 |
||